Navigation Links
CSA Medical announces first publication of the RejuvenAir Metered Cryospray System in the American Journal of Respiratory and Critical Care Medicine
Date:4/11/2017

LEXINGTON, Mass., April 11, 2017 /PRNewswire/ -- CSA Medical, Inc., a company focused on developing spray cryotherapy devices that selectively freeze and ablate unwanted tissue inside the body, today announced publication of a Research Letter in the American Journal of Respiratory and Critical Care Medicine (AJRCCM), which highlights the initial safety data for the RejuvenAir® System.

This data supports the safety of using Liquid Nitrogen Metered Cryospray™ (MCS) in the lobar and first segmental airways of the human bronchial system.  Published by principal investigators Drs. D-J Slebos, D Breen and K Irshad, the data set encompasses 16 patients presenting for peripheral lung nodule resection in two separate studies.  In total, 32 MCS were successfully delivered without device related adverse events in these distal airways, which supports the safety of delivering Liquid Nitrogen MCS with the RejuvenAir System.

The results of these two initial studies led to the initiation of a clinical trial investigating the safety and feasibility of delivering Liquid Nitrogen MCS therapy in chronic bronchitis patients.  This study (NCT02483637) is ongoing.

The Research Letter can be found at: http://dx.doi.org/10.1164/rccm.201611-2220LE

About Chronic Bronchitis

Chronic Bronchitis is the largest disease subset of Chronic Obstructive Pulmonary Disease (COPD). Bronchitis is inflammation of the bronchial airways. A chronic bronchitis diagnosis is defined by cough with productive sputum of three months duration for two consecutive years. In addition to a chronic inflammation, cough and increased production of mucus, chronic bronchitis may or may not present with obstruction/partially blocked airways due to swelling and excess mucus in the bronchi, or shortness of breath (dyspnea).

In the United States, there are an estimated 12.7 – 14.7 million people with COPD[1], and in 2011 approximately 10 million people sought medical attention for chronic bronchitis, a subset of COPD[2]. Approximately 700,000 people are hospitalized for symptoms/exacerbations of chronic bronchitis every year[3].

In Europe, there are approximately 23 million people with COPD[4].  There are approximately 1.5 million hospitalizations per year for COPD[5].

About CSA Medical

CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform utilizing unique properties of liquid nitrogen spray delivered by a software driven device with specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy unwanted tissue allowing for a rejuvenative pattern of healing.

The RejuvenAir System is currently under clinical investigation and is not commercially available.

To learn more about our technology, please visit www.csamedical.com.

RejuvenAir is a registered trademark of CSA Medical, Inc.

[1] American Lung Association, Trends in COPD: Morbidity and Mortality.

http://www.lung.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf

[2] ibid

[3] CDC/NCHS National Hospital Discharge Survey, 2010.

[4] Health at a Glance:  Europe (2012 and 2014 reports)  http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe-2012_9789264183896-en

[5] erswhitebook.org

Media Contact:
Amy Sarli
+1-781-538-4779

Photo(s):
https://www.prlog.org/12632624

Press release distributed by PRLog

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/csa-medical-announces-first-publication-of-the-rejuvenair-metered-cryospray-system-in-the-american-journal-of-respiratory-and-critical-care-medicine-300438306.html


'/>"/>
SOURCE CSA Medical
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Vasomedical Announces Financial Results for the First Quarter of 2013
2. CCS Medical Moves Forward as Medicare Winner
3. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
4. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
5. RAD Technology Medical Systems Delivers Innovative Time Saving Modular Construction At New Swedish Cancer Institute Facility
6. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
7. ACLS Online Course Manuals are Now Available at No Cost through United Medical Education
8. Statistical Challenges in Medical Device Trail Evaluation
9. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
10. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
11. Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/21/2017)... ... 21, 2017 , ... The American Hospital Association (AHA) has elected Claire Zangerle, ... to its Board of Trustees for a three-year term beginning January 1, 2018. ... and individuals that are committed to the improvement of health in their communities. Founded ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA ... Management System has assisted multiple clients in successfully passing audits such as ... Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
(Date:8/19/2017)... ... August 18, 2017 , ... Paragon and ... to help the cannabis industry move towards greater legitimacy. By incorporating IOTA’s unique ... technology with lower fees. Paragon will build a fully verifiable database to track ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... Yesterday, the ... KKK by saying there are two sides. There are not two sides to hatred, ... to rationalize violence and prejudice, and the NPEIV stands against all forms of such ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
Breaking Medicine News(10 mins):